Trading Signals: CGEN Stock Price Prediction and Forecast (Wed. Jun. 11, 2003 - Fri. May. 13, 2022)(Compugen Ltd.)
| CGEN latest price $4.2700 (0.71%) ($4.2700 - $4.2700) on Tue. Jan. 11, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.71% (three month average) | RSI | 47 | Latest Price | $4.2700(0.71%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CGEN declines -0.7% a day on average for past five trading days. | Weekly Trend | CGEN declines -2.4% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support CGEN advance at 0% a week (0% probability) XBI(85%) ARKG(81%) ARKK(81%) IBUY(79%) IWO(79%) | Factors Impacting CGEN price | CGEN will decline at least -2.355% in a week (0% probabilities). VIXM(-70%) VXX(-53%) UUP(-18%) UNG(-12%) TLT(-7%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.355% (StdDev 4.71%) | Hourly BBV | 1.2 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-3.05(-171.43%) | Resistance Level | $4.31 | 5 Day Moving Average | $4.19(1.91%) | 10 Day Moving Average | $4.29(-0.47%) | 20 Day Moving Average | $4.31(-0.93%) | To recent high | -40.4% | To recent low | 4.9% | Market Cap | $353m | | | | Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel. |